期刊文献+

辛伐他汀对前列腺上皮细胞RWPE-1增殖及凋亡的影响

Effects of simvastatin on the proliferation and apoptosis of prostatic epithelial RWPE-1 cells
下载PDF
导出
摘要 目的:探讨辛伐他汀对前列腺上皮细胞RWPE-1增殖及凋亡的影响。方法:设定不同浓度的辛伐他汀(0、10、20、40μmol/L)分别作用于体外培养的RWPE-1细胞,利用MTT法检测细胞增殖情况,流式细胞术检测细胞的凋亡情况。荧光定量RT-PCR检测RWPE-1细胞的Bcl-2、Bax、Cx43 mRNA的表达,Western印迹检测Bcl-2、Bax、Cx43蛋白的表达。结果:MTT法检测辛伐他汀(10、20、40μmol/L)作用于RWPE-1细胞72 h后,对RWPE-1细胞的抑制率分别为(21.07±6.41)%、(34.87±9.65)%和(47.18±10.88)%,与对照组[(1.21±0.54)%]比较有显著差异(P<0.05),并且呈明显的剂量依赖关系(P<0.05);处理72 h后各组的凋亡指数分别为:10μmol/L组(0.066±0.016)%,20μmol/L组(0.126±0.023)%,40μmol/L组(0.192±0.025)%,与对照组[(0.015±0.005)%]相比差异显著(P<0.01),且呈剂量依赖关系(P<0.05)。荧光定量PCR检测显示随着辛伐他汀浓度升高Bcl-2基因表达逐渐下调(P<0.05),Bax和Cx43基因表达逐渐上调(P<0.05),并且呈剂量依赖关系(P<0.05)。Western印迹检测显示RWPE-1细胞内Bcl-2蛋白的表达随辛伐他汀浓度的增高逐渐下调(P<0.05),Bax蛋白逐渐上调(P<0.05),Cx43蛋白逐渐上调(P<0.01),并且皆呈剂量依赖关系(P<0.05)。Cx43的表达与Bcl-2的表达呈负相关,与Bax的表达呈正相关。结论:辛伐他汀可能通过影响细胞间隙连接通讯来抑制前列腺上皮细胞增殖并诱导其凋亡。 Objective: To investigate the effects of simvastatin on the proliferation and apoptosis of prostatic epithelial RWPE-1 cells. Methods: RWPE-1 cells cultured in vitro were treated with simvastatin at0, 10, 20, and40 μmol/L for 24, 48, and 72 hours followed by determination of their proliferation by MTT assay, and their apoptosis by flow cytometry. The mRNA and protein expressions of Bcl-2, Bax, and Cx43 were detected by fluorescence quantitative RT-PCR and Western blot, respectively. Results : After 72 hours of treatment with simvastatin at 10, 20, and 40 μmol/L, the inhibition rates of the RWPE-1 cells were (21.07 ± 6.41 )% , ( 34.87 ± 9.65 ) %, and (47.18 ± 10.88 ) %, respectively, significantly higher than ( 1.21 ±0.54 ) % in the control group ( P 〈 0.05 ) and in a dose-dependent manner ( P 〈 0.05 ) ; the cell apoptosis rates were (0. 066 ± 0. 016 ) % , (0. 126 ± 0. 023 ) %, and (0. 192 ±.025)% , respectively, remarkably higher than (0.015 ± 0. 005)% in the control (P 〈 0.05) and also in a dose-depend-ent manner ( P 〈 0.05 ) ; the mRNA and protein expressions of Bcl-2 were decreasing while those of Bax and Cx43 increasing with the increased concentration of simvastatin (P 〈 0.05). The expression of Cx43 was correlated negatively with that of Bcl-2 but positively with that of Bax. Conclusion : Simvastatin inhibits the proliferation of prostate epithelial cells and induce their apoptosis by acting on the gap junctional intercellular communication.
出处 《中华男科学杂志》 CAS CSCD 北大核心 2015年第2期113-118,共6页 National Journal of Andrology
基金 福建省自然科学基金(2012J05164)~~
关键词 辛伐他汀 良性前列腺增生 细胞增殖 细胞凋亡 CX43 simvastatin benign prostatic hyperplasia proliferation apoptosis Cx43
  • 相关文献

参考文献18

  • 1Madersbacher S, Alivizatos G, Nordling J, et al. EAU 2004 guide- lines on assessment, therapy and follow-up of men with lower uri- nary tract symptoms suggestive of benign prostatic obstruction ( B PH guidelines). Eur Urol, 2004, 46 (5) : 547-554. 被引量:1
  • 2Robertson C, Link CL, Onel E, et al. The impact of lower uri- nary tract symptoms and comorbidities on quality of life: The BACH and UREPIK studies. BJU Int, 2007, 99(2) : 347-354. 被引量:1
  • 3Saigal CS, Joyce G. Economic costs of benign prostatic hyperpla- sia in the private sector. J Urol, 2005, 173(4) : 1309-1313. 被引量:1
  • 4Zhou Q, Liao JK. Statins and cardiovascular diseases : From cho- lesterol lowering to pleiotropy. Curr Pharm Des, 2009, 15 (5) : 467 -478. 被引量:1
  • 5St Sauver JL, Jacobson DJ, MeGree ME, et al. Protective associ- ation between nonsteroidal antiinflammatory drug use and mea- sures of benign prostatic hyperplasia. Am J Epidemiol, 2006, 164(8) : 760-768. 被引量:1
  • 6Sciarra A, Di Silverio F, Salciccia S, et al. Inflammation and chronic prostatic diseases: Evidence for a link? Eur Urol, 2007, 52(4) : 964-972. 被引量:1
  • 7Lucia MS, Lambert JR. Growth factors in benign prostatic hyper- plasia : Basic science implications. Curt Urol Rep, 2008, 9 (4) : 272-278. 被引量:1
  • 8St Sauver JL, Jacobsen S J, Jacobson D J, et al. Statin use and decreased risk of benign prostatic enlargement and lower urinary tract symptoms. BJU Int, 2011, 107(3) : 443-450. 被引量:1
  • 9杨明根,郑周达,林海利,庄志明,林天旗.他汀类药物的使用与良性前列腺增生和下尿路症状相关性的临床研究[J].中华男科学杂志,2014,20(9):798-802. 被引量:7
  • 10Solomon KR, Freeman MR. Do the cholesterol-lowering proper- ties of statins affect cancer risk? Trends Endocrinol Metab, 2008, 19(4) : 113-121. 被引量:1

二级参考文献24

  • 1梁飞宇,屈晓冰,赵晓昆.炎症与良性前列腺增生症[J].国外医学(老年医学分册),2005,26(5):193-196. 被引量:4
  • 2Murry SA,Davis K,Fishman LM,et al.Alphal connexin43 gap junction are decreased in human adrenocortical tumors.J Clin Endocrinol Metab,2000,85:890-895. 被引量:1
  • 3Habermann H,Ray V,Habermann W,et al.Alterations in gap junction protein expression in human benign prostatic hyperplasia and prostate cancer.J Urol,2001,166:2267-2272. 被引量:1
  • 4Tsai H,Werber L,Davia MO,et al.Reduce connexin 43 expression in high grade,human prostatic adenocarcinoma cells.Biochem Biophys Res Commun,1996,227:64-69. 被引量:1
  • 5Mehta PP,Perez-Stable C,Nadji M,et al.Suppression of human prostate cancer cell growth by forced expression of connexin gene.Dev Gen,1999,24:91-110. 被引量:1
  • 6Madersbacher S, Alivizatos G, Nordling J, et al. EAU 2004 guide- lines on assessment, therapy and follow-up of men with lower uri- nary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol, 2004, 46(5) : 547-554. 被引量:1
  • 7Robertson C, Link CL, Onel E, et al. The impact of lower uri- nary tract symptoms and comorbidities on quality of life: The BACH and UREPIK studies. BJU Int, 2007, 99(2) : 347-354. 被引量:1
  • 8Saigal CS, Joyce G. Economic costs of benign prostatic hyperpla- sia in the private sector. ] Urol, 2005, 173(4) : 1309-1313. 被引量:1
  • 9Zhou Q, Liao JK. Statins and cardiovascular diseases : From cho- lesterol lowering to pleiotropy. Curr Pharm Des, 2009, 15 (5) : 467-478. 被引量:1
  • 10St Sauver JL, Jacobson DJ, McGree ME, et al. Protective associ- ation between nonsteroidal antiinflammatory drug use and mea- sures of benign prostatic hyperplasia. Am J Epidemiol, 2006, 164(8) : 760-768. 被引量:1

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部